Amphastar Pharmaceuticals Inc.
AMPH
|
|
| |
|
| Trading Volume | 17,126 |
|
|
63.45 - 38.63 |
| Market Cap Full | $ 2.3B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | -2.3% | -29.1% | 33.8% | 52.9% |
| Q2 | - | -7% | 53.3% | -3.1% |
| Q3 | - | 12% | -20% | -19.2% |
| Q4 | - | -15.3% | 35.2% | -0.3% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.3 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -13.7 | -12.7 | -5.8 | -8.9 | 5.8 | -4.5 | 7.9 | 12 | - | - | - | - |
| 2023 | |||||||||||
| 8 | 5.3 | 17.7 | -4.6 | 24 | 29.5 | 5.6 | -12.2 | -13.7 | -1.6 | 24.4 | 9.8 |
| 2022 | |||||||||||
| -1.7 | 20 | 29.6 | -1.2 | 6.1 | -7.6 | 6.9 | -20.4 | -5.1 | 10 | -4.6 | -5 |
| 2021 | |||||||||||
| -9.6 | -3.6 | 3.3 | -4 | 8.7 | 6.6 | 2.9 | -5.2 | -2.1 | -2.9 | 5.9 | 18.7 |
| 2020 | |||||||||||
| -0.9 | -19.7 | -2.4 | 14.2 | 10 | 20.5 | -10.9 | 1.8 | -8 | 4.5 | -9.3 | 13.2 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | 0.5 | 0.5 | 0.1 | 0.1 |
| Q2 | 0.5 | 0.3 | 0.2 | 0 |
| Q3 | 0.9 | 0.3 | 0.6 | 0.1 |
| Q4 | 0 | 0.6 | 0.4 | -0.1 |
| A | 1.9 | 1.7 | 1.3 | 0 |